.Nature Medication, Published online: 30 July 2024 doi:10.1038/ d41591-024-00054-wThe antitoxin-- medication conjugate (ADC) tisotumab vedotin led to strengthened progression-free as well as overall survival, triggering FDA approval as well as a brand new procedure option for patients.